Anti-RDM1 antibodies are used in the immunodetection of the protein RAD52 motif containing 1. In humans, the canonical protein has a reported length of 284 amino acid residues and a mass of 32 kDa. Its subcellular localization is in the nucleus and cytoplasm. Up to 12 different isoforms have been reported for this protein. It is notably expressed in the testis. RDM1 is believed to confer resistance to the antitumor agent cisplatin. Synonyms for this target antigen include RAD52 homolog B, RAD52 motif 1, and RAD52 motif-containing protein 1. RDM1 gene orthologs have been reported in the mouse, rat, frog, zebrafish, chimpanzee and chicken species. A number of RDM1 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.